Cholangiocarcinoma Differential Diagnoses

  • Upload
    mmmm

  • View
    213

  • Download
    0

Embed Size (px)

DESCRIPTION

http://emedicine.medscape.com

Citation preview

  • 10/12/2015 CholangiocarcinomaDifferentialDiagnoses

    http://emedicine.medscape.com/article/277393differential 1/2

    CholangiocarcinomaDifferentialDiagnosesAuthor:PeterEDarwin,MDChiefEditor:JulesEHarris,MD,FACP,FRCPCmore...

    Updated:Mar26,2015

    DifferentialDiagnosesBileDuctStrictures

    BileDuctTumors

    BiliaryDisease

    BiliaryObstruction

    Cholangitis

    Cholecystitis

    CholedochalCysts

    Gallstones(Cholelithiasis)

    Workup

    ContributorInformationandDisclosuresAuthorPeterEDarwin,MDProfessorofMedicine,DirectorofGIEndoscopy,DepartmentofMedicine,DivisionofGastroenterology,UniversityofMarylandSchoolofMedicine

    PeterEDarwin,MDisamemberofthefollowingmedicalsocieties:AmericanSocietyforGastrointestinalEndoscopy

    Disclosure:Nothingtodisclose.

    Coauthor(s)AndrewScottKennedy,MDPhysicianinChief,RadiationOncology

    AndrewScottKennedy,MDisamemberofthefollowingmedicalsocieties:AlphaOmegaAlpha,AmericanAssociationforCancerResearch,AmericanSocietyforRadiationOncology,RadiologicalSocietyofNorthAmerica,AmericasHepatoPancreatoBiliaryAssociation,AmericanSocietyofClinicalOncology

    Disclosure:Nothingtodisclose.

    JenniferLynnBonheur,MDAttendingPhysician,DivisionofGastroenterology,LenoxHillHospital

    JenniferLynnBonheur,MDisamemberofthefollowingmedicalsocieties:AmericanGastroenterologicalAssociation,AmericanSocietyforGastrointestinalEndoscopy,NewYorkSocietyforGastrointestinalEndoscopy,NewYorkAcademyofSciences,SigmaXi

    Disclosure:Nothingtodisclose.

    SpecialtyEditorBoardFranciscoTalavera,PharmD,PhDAdjunctAssistantProfessor,UniversityofNebraskaMedicalCenterCollegeofPharmacyEditorinChief,MedscapeDrugReference

    Disclosure:ReceivedsalaryfromMedscapeforemployment.for:Medscape.

    BenjaminMovsas,MD

    BenjaminMovsas,MDisamemberofthefollowingmedicalsocieties:AmericanCollegeofRadiology,AmericanRadiumSociety,AmericanSocietyforRadiationOncology

    Disclosure:Nothingtodisclose.

    ChiefEditorJulesEHarris,MD,FACP,FRCPCClinicalProfessorofMedicine,SectionofHematology/Oncology,UniversityofArizonaCollegeofMedicine,ArizonaCancerCenter

    JulesEHarris,MD,FACP,FRCPCisamemberofthefollowingmedicalsocieties:AmericanAssociationfortheAdvancementofScience,AmericanSocietyofHematology,CentralSocietyforClinicalandTranslationalResearch,AmericanSocietyofClinicalOncology

    Disclosure:Nothingtodisclose.

    References

    1. DouglassHO,TepperJ,LeichmanL.Neoplasmsoftheextrahepaticbileducts.In:HollandJF,etal,eds.CancerMedicine.Vol2.Philadelphia,Pa:Lea&Febiger.1993:145562.

    2. LakeJR.Benignandmalignantneoplasmsofthegallbladder,bileductsandampulla.In:SleisingerMH,FordtranJS,eds.GastrointestinalDisease.5thed.Vol2.Philadelphia,Pa:WBSaunders.1993:18911902.

    3. LotzeMT,FlickingerJC,CarrBI.Hepatobiliaryneoplasms.DevitaV,HellmanS,RosenbergS.Cancer:PrinciplesandPracticeofOncology.4th.Philadelphia,Pa:Lippincott1993.883907.

    4. deGroenPC,GoresGJ,LaRussoNF,etal.Biliarytractcancers.NEnglJMed.1999Oct28.

  • 10/12/2015 CholangiocarcinomaDifferentialDiagnoses

    http://emedicine.medscape.com/article/277393differential 2/2

    MedscapeReference2011WebMD,LLC

    341(18):136878.[Medline].

    5. KlatskinG.Adenocarcinomaofthehepaticductatitsbifurcationwithintheportahepatis.Anunusualtumorwithdistinctiveclinicalandpathologicalfeatures.AmJMed.1965Feb.38:24156.[Medline].

    6. ClaryB,JarniganW,PittH,etal.Hilarcholangiocarcinoma.JGastrointestSurg.2004MarApr.8(3):298302.[Medline].

    7. SingalAK,VautheyJN,GradyJJ,StroehleinJR.Intrahepaticcholangiocarcinomafrequencyanddemographicpatterns:thirtyyeardatafromtheM.D.AndersonCancerCenter.JCancerResClinOncol.2011Jul.137(7):10718.[Medline].

    8. AmericanCancerSocietyStatistics.EstimatedNewCancerCasesandDeaths,2007.Availableathttp://www.cancer.org/downloads/stt/CFF2007EstCsDths07.pdf.Accessed:April11,2008.

    9. BiliaryTractCancer.SchottenfeldD,FraumeniJ.Cancer.EpidemiologyandPrevention.3rdEdition.OxfordUniversityPress2006.787800.

    10. ChalasaniN,BaluyutA,IsmailA,etal.Cholangiocarcinomainpatientswithprimarysclerosingcholangitis:amulticentercasecontrolstudy.Hepatology.2000Jan.31(1):711.[Medline].

    11. TravisLB,HauptmannM,GaulLK,StormHH,GoldmanMB,NybergU,etal.Sitespecificcancerincidenceandmortalityaftercerebralangiographywithradioactivethorotrast.RadiatRes.2003Dec.160(6):691706.[Medline].

    12. LiJS,HanTJ,JingN,LiL,ZhangXH,MaFZ,etal.Obesityandtheriskofcholangiocarcinoma:ametaanalysis.TumourBiol.2014Apr13.[Medline].

    13. KeidingS,HansenSB,RasmussenHH,etal.Detectionofcholangiocarcinomainprimarysclerosingcholangitisbypositronemissiontomography.Hepatology.1998Sep.28(3):7006.[Medline].

    14. PetrowskyH,WildbrettP,HusarikDB.ImpactofIntegratedPETandCTonstagingandmanagementofglabladdercancerandcholangiocarcinoma.JHepatol.2006.EpubApr19:

    15. FritscherRavensA,BroeringDC,KnoefelWT,etal.EUSguidedfineneedleaspirationofsuspectedhilarcholangiocarcinomainpotentiallyoperablepatientswithnegativebrushcytology.AmJGastroenterol.2004Jan.99(1):4551.[Medline].

    16. SimmonsDT,BaronTH,PetersonBT.ANovelEndoscopicApproachtoBrachytherapyintheManagementofHilarCholangiocarcinoma.AmJGastroenterol.2006.Epubaheadofprint:

    17. ButrosSR,ShenoyBhangleA,MuellerPR,ArellanoRS.Radiofrequencyablationofintrahepaticcholangiocarcinoma:feasability,localtumorcontrol,andlongtermoutcome.ClinImaging.2014Feb7.[Medline].

    18. KidaM,MiyazawaS,IwaiT,etal.Endoscopicmanagementofmalignantbiliaryobstructionbymeansofcoveredmetallicstents:primarystentplacementvs.reintervention.Endoscopy.2011Dec.43(12):103944.[Medline].

    19. OrtnerMA,LiebetruthJ,SchreiberS,etal.Photodynamictherapyofnonresectablecholangiocarcinoma.Gastroenterology.1998Mar.114(3):53642.[Medline].

    20. OrtnerME,CacaK,BerrF,etal.Successfulphotodynamictherapyfornonresectablecholangiocarcinoma:arandomizedprospectivestudy.Gastroenterology.2003Nov.125(5):135563.[Medline].

    21. ThongprasertS,NapapanS,CharoentumC,MoonprakanS.PhaseIIstudyofgemcitabineandcisplatinasfirstlinechemotherapyininoperablebiliarytractcarcinoma.AnnOncol.2005Feb.16(2):27981.[Medline].

    22. ThongprasertS.Theroleofchemotherapyincholangiocarcinoma.AnnOncol.2005.16Suppl2:ii936.[Medline].

    23. NationalComprehensiveCancerNetworkClinicalPracticeGuidelinesinOncology.Availableathttp://www.nccn.org/professionals/physician_gls/default.asp.

    24. HeimbachJK,HaddockMG,AlbertsSR,etal.Transplantationforhilarcholangiocarcinoma.LiverTranspl.2004Oct.10(10Suppl2):S658.[Medline].

    25. ShenWF,ZhongW,LiuQ,SuiCJ,HuangYQ,YangJM.AdjuvantTranscatheterArterialChemoembolizationforIntrahepaticCholangiocarcinomaafterCurativeSurgery:RetrospectiveControlStudy.WorldJSurg.2011Jun23.[Medline].

    26. PolistinaFA,GuglielmiR,BaiocchiC,etal.Chemoradiationtreatmentwithgemcitabineplusstereotacticbodyradiotherapyforunresectable,nonmetastatic,locallyadvancedhilarcholangiocarcinoma.Resultsofafiveyearexperience.RadiotherOncol.2011May.99(2):1203.[Medline].

    27. GhafooriAP,NelsonJW,WillettCG,etal.Radiotherapyinthetreatmentofpatientswithunresectableextrahepaticcholangiocarcinoma.IntJRadiatOncolBiolPhys.2011Nov1.81(3):6549.[Medline].

    28. GundersonLL,WillettCG.Pancreasandhepatobiliarytract.PerezCA,BradyLW,etal.PrinciplesandPracticeofRadiationOncology.3rded.Philadelphia,Pa:LippincottRaven1998:14671488.

    29. LillemoeK,KennedyA,PicusJ.Clinicalmanagementofcarcinomaofthebiliarytree.KelsenDP,DalyJM,KernSE,etal.GastrointestinalOncology:PrinciplesandPractices.Philadelphia,Pa:LippincottWilliams&Wilkins2001.

    30. UchidaM,IshibashiM,TomitaN,etal.Hilarandsuprapancreaticcholangiocarcinoma:valueof3DangiographyandmultiphasefusionimagesusingMDCT.AJRAmJRoentgenol.2005May.184(5):15727.[Medline].